HCA Healthcare, Inc. - Common Stock (HCA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
HCA on NYSE
Shares outstanding
247,618,102
Price per share
$466.86
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
136,386,916
Total reported value
$58,109,184,554
% of total 13F portfolios
0.05%
Share change
-10,071,065
Value change
-$4,115,514,331
Number of holders
1,271
Price from insider filings
$466.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HCA Healthcare, Inc. - Common Stock (HCA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 4.9% $4,064,772,478 12,133,287 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 1,271 institutional investors reported holding 136,386,916 shares of HCA Healthcare, Inc. - Common Stock (HCA). This represents 55% of the company’s total 247,618,102 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of HCA Healthcare, Inc. - Common Stock (HCA) together control 36% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 6% 14,894,675 -3.8% 0.1% $6,348,110,485
BlackRock, Inc. 5% 12,467,326 -3.7% 0.09% $5,313,574,326
Sanders Capital, LLC 4.3% 10,675,663 -3.8% 5.6% $4,549,967,571
STATE STREET CORP 3% 7,490,604 -5.9% 0.11% $3,192,495,425
Capital World Investors 2% 4,959,336 +3.8% 0.29% $2,113,661,728
First Eagle Investment Management, LLC 1.6% 3,919,472 -6.9% 3% $1,670,478,761
WELLINGTON MANAGEMENT GROUP LLP 1.6% 3,880,196 -5.6% 0.29% $1,653,739,536
GEODE CAPITAL MANAGEMENT, LLC 1.5% 3,650,140 -3.9% 0.1% $1,547,861,523
JPMORGAN CHASE & CO 1.2% 2,987,069 -8.9% 0.08% $1,273,089,601
MORGAN STANLEY 0.86% 2,129,892 -4.5% 0.05% $907,760,960
BANK OF AMERICA CORP /DE/ 0.84% 2,072,844 -9.7% 0.07% $883,445,983
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.83% 2,065,225 +1.8% 0.56% $880,198,895
FMR LLC 0.77% 1,905,133 +19% 0.04% $811,968,123
NORTHERN TRUST CORP 0.73% 1,819,159 -4.2% 0.1% $775,325,567
GOLDMAN SACHS GROUP INC 0.73% 1,812,212 +10% 0.11% $772,364,951
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.69% 1,716,415 -13% 0.16% $731,536,073
UBS Group AG 0.65% 1,602,599 +2.4% 0.13% $683,027,693
Nuveen, LLC 0.61% 1,521,470 -7.5% 0.17% $648,450,513
VIKING GLOBAL INVESTORS LP 0.56% 1,380,583 -26% 1.5% $588,404,475
JANUS HENDERSON GROUP PLC 0.5% 1,242,882 -1.6% 0.24% $529,720,228
BARCLAYS PLC 0.5% 1,230,892 -2.4% 0.2% $524,606,169
FRANKLIN RESOURCES INC 0.47% 1,173,404 -18% 0.13% $500,104,784
Bank of New York Mellon Corp 0.46% 1,126,683 -2% 0.09% $480,192,285
Legal & General Group Plc 0.45% 1,124,511 +0.76% 0.11% $479,266,586
Invesco Ltd. 0.44% 1,100,929 +1.1% 0.07% $469,215,948

Institutional Holders of HCA Healthcare, Inc. - Common Stock (HCA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,157,195 $1,010,762,422 +$71,173,802 $466.86 88
2025 Q3 136,386,916 $58,109,184,554 -$4,115,514,331 $426.20 1,271
2025 Q2 146,598,810 $56,127,057,771 -$1,853,153,800 $383.10 1,239
2025 Q1 152,192,884 $52,564,357,865 -$2,006,251,000 $345.55 1,214
2024 Q4 158,412,925 $47,557,475,465 -$8,742,290 $300.15 1,169
2024 Q3 157,628,473 $63,992,248,095 -$2,602,260,628 $406.43 1,192
2024 Q2 163,570,360 $52,579,318,347 -$183,070,166 $321.28 1,151
2024 Q1 163,721,760 $54,559,435,398 -$1,094,106,832 $333.53 1,116
2023 Q4 168,060,091 $45,488,018,617 -$285,213,231 $270.68 1,047
2023 Q3 169,154,472 $41,607,918,680 -$1,185,806,069 $245.98 989
2023 Q2 173,400,079 $52,556,079,546 -$666,679,406 $303.48 1,006
2023 Q1 175,196,823 $46,186,378,435 -$839,492,963 $263.68 958
2022 Q4 179,614,269 $43,106,998,862 -$1,135,008,361 $239.96 949
2022 Q3 184,870,749 $34,004,075,333 -$752,760,047 $183.79 849
2022 Q2 188,490,291 $31,685,644,085 -$1,589,511,131 $168.06 854
2022 Q1 198,438,957 $49,759,228,094 -$1,674,801,898 $250.62 950
2021 Q4 204,993,837 $52,647,373,530 -$1,558,591,258 $256.92 931
2021 Q3 210,742,269 $51,162,204,632 -$2,696,772,377 $242.72 870
2021 Q2 221,449,830 $45,771,072,350 -$1,473,962,964 $206.74 805
2021 Q1 231,377,874 $43,551,161,088 -$1,184,824,119 $188.34 777
2020 Q4 237,137,952 $38,991,278,461 +$223,535,805 $164.46 765
2020 Q3 237,038,075 $29,542,477,145 +$374,442,548 $124.68 709
2020 Q2 233,611,421 $22,662,190,032 +$114,158,905 $97.06 676
2020 Q1 233,576,916 $20,985,688,732 -$500,973,286 $89.85 691
2019 Q4 237,576,726 $35,070,820,741 +$69,075,392 $147.81 707
2019 Q3 237,425,759 $28,552,762,563 -$390,813,393 $120.42 668
2019 Q2 240,503,276 $32,450,213,560 +$200,307,836 $135.17 666
2019 Q1 242,859,071 $31,613,110,993 -$72,604,081 $130.38 692
2018 Q4 243,226,790 $30,217,039,773 -$151,772,142 $124.45 691
2018 Q3 244,050,841 $33,880,893,815 -$405,124,383 $139.12 649
2018 Q2 247,244,952 $25,314,355,349 -$453,682,956 $102.60 640
2018 Q1 251,241,956 $24,303,990,209 -$605,356,676 $97.00 607
2017 Q4 257,576,538 $22,569,606,948 -$1,125,863,838 $87.84 557
2017 Q3 270,067,721 $21,491,862,815 +$432,919 $79.59 523
2017 Q2 269,733,979 $23,523,687,954 -$283,225,148 $87.20 565
2017 Q1 273,801,978 $24,364,900,598 +$1,921,669,692 $88.99 569
2016 Q4 273,996,527 $20,276,620,099 +$125,377,695 $74.02 565
2016 Q3 271,673,421 $20,535,113,085 -$512,554,258 $75.63 577
2016 Q2 277,691,100 $21,385,005,482 -$925,974,468 $77.01 606
2016 Q1 289,930,780 $22,623,817,519 -$261,940,529 $78.05 581
2015 Q4 296,382,283 $20,045,696,881 -$1,056,897,195 $67.63 575
2015 Q3 309,503,569 $23,938,836,528 -$349,165,270 $77.36 630
2015 Q2 313,081,744 $28,402,056,579 -$595,630,068 $90.72 651
2015 Q1 321,227,970 $24,164,161,122 +$211,563,363 $75.23 591
2014 Q4 318,310,377 $23,361,922,697 -$834,223,912 $73.39 540
2014 Q3 329,453,347 $23,233,763,725 +$543,310,103 $70.52 499
2014 Q2 323,509,963 $18,244,634,062 -$766,287,989 $56.38 437
2014 Q1 337,917,820 $17,736,335,008 +$311,154,994 $52.50 399